Vaishali Pharma Limited

₹6.94As of Sun 8 Nov 2026, 12:00 UTC
NSE:VAISHALIHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 7.36%
Div yield —
ROE 6.21%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.46
PE TTM 20.48
TSR TTM (30.88%)
Mkt cap ₹905.4M
ROIC 3.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹7.30
5.22%
202.07%
Hold 2|1|1|5|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.12
0.12
0.11
0.12
18.00%
5.62%
(1.67%)
0.49%
Revenue₹M
44.31
43.39
42.69
44.59
12.90%
7.94%
4.68%
3.85%
Peers (US$9.419M)
Cap (US$)
PE
12.08M
25.54x
Capital
TTM
5Y
10Y
Leveragex
1.218
0.139
0.146
EBIT/Intx
2.702
0.291
0.293
Own earn%
(88.52)
80.96
102.67
Sh yield%
50.41
37.84
33.89
Owners
Insiders/Inst%
13.56
30.14
Short interest%
2.85
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
2